Pygeum (Prunus africana): BPH Relief From African Bark — A Research-Backed Guide
⚡ 60-Second Summary
Pygeum is a standardized lipophilic extract from the bark of Prunus africana, an African plum tree. Its active constituents — phytosterols (beta-sitosterol), ferulic acid esters, and pentacyclic triterpenes — reduce prostate inflammation and improve bladder outlet function without affecting testosterone or PSA levels.
Best evidence: The 2002 Cochrane review of 18 RCTs found pygeum reduced nocturia by 19%, increased peak urinary flow by 23%, and improved overall symptom scores vs placebo. These are meaningful improvements for BPH-related urinary symptoms.
Typical dose: 100 mg/day standardized extract (13% total sterols), in two divided doses with food. Often combined with saw palmetto. Does not replace physician-supervised BPH treatment for moderate-to-severe disease.
What is pygeum?
Pygeum (Prunus africana, also formerly classified as Pygeum africanum) is a large evergreen tree native to the mountain forests of sub-Saharan Africa. Its bark has been used in traditional African medicine for centuries to treat urinary discomfort and prostate-related symptoms. The pharmaceutical-grade supplement is a standardized lipophilic extract prepared by organic solvent extraction of the dried bark, yielding a concentrated mixture of biologically active lipid-soluble compounds.
In Europe, particularly France and Germany, pygeum extract has been prescribed for BPH symptoms since the 1960s under the brand name Tadenan. In North America, it is available as an over-the-counter dietary supplement, typically sold alone or in combination prostate formulas alongside saw palmetto, stinging nettle root, and zinc.
How pygeum works
Pygeum extract's BPH-relevant effects arise from several classes of phytochemicals:
- Phytosterols (beta-sitosterol, sitostanol): Inhibit prostaglandin synthesis in prostate tissue, reducing local inflammation and edema that contribute to outlet obstruction.
- Ferulic acid esters (n-docosanol, n-tetracosanol): Reduce prolactin-stimulated uptake of testosterone in prostate cells, decreasing androgen-driven growth stimulation without inhibiting 5-alpha reductase.
- Pentacyclic triterpenes (ursolic acid, oleanolic acid): Anti-inflammatory and antiedematous effects, reducing swelling of periprostatic tissue.
- Atraric acid: Androgen receptor antagonist activity, adding another layer of androgen-signal dampening without systemic hormone suppression.
The net result is reduced prostatic inflammation, less paracrine growth stimulation, and improved bladder neck compliance — all without affecting circulating testosterone or DHT at the systemic level.
Evidence-based benefits of pygeum
1. BPH urinary symptom relief (primary indication)
The foundational evidence comes from the Cochrane systematic review (Wilt et al., 2002), analyzing 18 randomized controlled trials with 1,562 participants. Key findings:
- Nocturia reduced by approximately 19% vs placebo
- Peak urinary flow rate increased by approximately 23% vs placebo
- Self-reported symptom improvement was roughly twice as likely with pygeum as with placebo
- Residual urine volume trended downward (improved bladder emptying)
Limitations noted in the Cochrane review: most trials were short (1–3 months), used varying extract preparations, and were of moderate methodological quality. Longer-term data and standardized symptom scoring (IPSS) were largely absent. Nevertheless, the consistency across trials supports a real effect.
2. Nocturia specifically
Multiple individual trials showed statistically significant reductions in nighttime urination frequency. A trial by Barlet et al. (1990, n=263) found pygeum reduced nocturia by 32% over 60 days. Nocturia is often the most quality-of-life-disruptive BPH symptom, making this a clinically meaningful endpoint.
3. No effect on prostate size or PSA
Unlike 5-alpha reductase inhibitors (finasteride, dutasteride), pygeum does not reduce prostate volume or PSA levels. This is simultaneously a limitation (no structural modification of the gland) and an advantage: PSA remains a valid prostate cancer screening tool during pygeum use, and androgenic side effects are not observed.
Supplement forms and standardization
| Form | Standardization | Notes |
|---|---|---|
| Standardized lipophilic extract (solo) | 13% total sterols | The pharmaceutical-grade form used in Cochrane-reviewed trials. This is the form to seek. |
| Pygeum + saw palmetto combination | Varies by product | Common prostate formula. Mechanistic complementarity is plausible (different pathways), but combination-specific RCTs are limited. |
| Prostate support blends | Variable — check label | Often include pygeum, saw palmetto, nettle root, beta-sitosterol, and zinc. Dose of each component may be subtherapeutic. |
| Raw bark powder | Unstandardized | Avoid. Active constituents are lipophilic and require solvent extraction to concentrate effectively. |
How much pygeum should you take?
Based on Cochrane-reviewed trial doses:
- Standard dose: 100 mg/day of 13%-sterol-standardized lipophilic extract, taken as 50 mg twice daily with meals
- Range used in trials: 75–200 mg/day; 100 mg/day is the most commonly studied and appears to be the therapeutic sweet spot
- Duration: Clinical benefit typically appears within 4–8 weeks; most trials ran 1–3 months
Practical guidance: take with a fat-containing meal to improve absorption of lipophilic constituents. If using a combination formula, verify the pygeum dose per serving meets the 50–100 mg threshold — many proprietary blends contain subtherapeutic amounts.
Safety and side effects
Pygeum has a good short-term safety profile. The Cochrane review found adverse events were mild and gastrointestinal in nature, occurring at similar rates in treatment and placebo groups. No serious adverse events were attributed to pygeum in any reviewed trial.
Specific safety considerations
- GI tolerability: Mild nausea or stomach discomfort in some users; taking with food largely resolves this.
- Hormonal effects: None documented. Unlike finasteride, pygeum does not alter serum testosterone, DHT, FSH, or LH. Sexual function is unaffected.
- PSA validity: Pygeum does not suppress PSA, so prostate cancer screening via PSA remains valid. This is an advantage over finasteride and dutasteride, which lower PSA by approximately 50%.
- Long-term data: Trials longer than 6 months are lacking. Given the benign mechanism and adverse event profile, long-term use appears likely safe, but formal confirmation is absent.
Drug and nutrient interactions
- Alpha-blockers (tamsulosin, alfuzosin, terazosin) — pygeum is commonly combined with alpha-blockers in European clinical practice. No pharmacokinetic interaction documented, but additive hypotensive effect (dizziness on standing) is possible. Inform prescriber.
- 5-alpha reductase inhibitors (finasteride, dutasteride) — different mechanism; additive BPH benefit is plausible. No safety concern documented.
- Anticoagulants — ferulic acid esters may have mild antiplatelet activity. Caution with warfarin or high-dose aspirin; inform prescriber.
- Saw palmetto — commonly co-supplemented; no adverse interaction documented and the combination is mechanistically rationale-based.
Sustainable sourcing: an important concern
Prunus africana is listed in CITES Appendix II due to historic overharvesting for pharmaceutical export. Demand for bark has outpaced sustainable yield in several African countries. When purchasing pygeum supplements, look for:
- Brands sourcing from certified sustainable plantations or certified ethical wild-harvest operations
- CITES-compliant sourcing documentation
- Fair-trade certifications where available
Overharvested wild bark is also more likely to be adulterated or substituted, affecting both efficacy and safety.
Who might benefit — and who shouldn't rely on pygeum alone
| Most likely to benefit | Should use caution or consult a clinician |
|---|---|
| Men with mild-to-moderate BPH seeking urinary symptom relief | Men with moderate-to-severe BPH (IPSS >19) — pygeum should supplement, not replace, physician-supervised treatment |
| Men who want BPH support without PSA suppression | Men with any suspicion of prostate cancer — get PSA and urological evaluation before starting any supplement |
| Men on alpha-blockers who want adjunct botanical support | Men taking anticoagulants — inform prescriber due to mild antiplatelet activity |
| Men seeking a pygeum + saw palmetto dual-mechanism approach | Anyone expecting pygeum to shrink the prostate or lower PSA — it does neither |
Frequently asked questions
Does pygeum work for BPH?
Yes, with moderate confidence. The 2002 Cochrane review of 18 RCTs found significant improvements in nocturia, urinary flow rate, and overall symptom scores vs placebo. Effect sizes are modest to moderate.
What dose of pygeum should I take?
100 mg/day of standardized extract (13% total sterols), divided into two 50 mg doses with meals. This is the dose with the strongest clinical evidence base.
Is pygeum the same as saw palmetto?
No. Different plants, different mechanisms. Saw palmetto primarily inhibits 5-alpha reductase (reducing DHT). Pygeum works mainly through anti-inflammatory phytosterols and ferulic acid esters. They are often combined because their mechanisms are complementary.
Does pygeum affect testosterone or PSA?
No. Pygeum does not inhibit 5-alpha reductase, does not lower DHT or PSA, and does not affect circulating testosterone. PSA screening remains valid while taking pygeum — a key advantage over finasteride.
Is pygeum safe long term?
Short-term safety is well supported with only mild GI side effects reported. Long-term data beyond 6 months are lacking. Inform your prescriber of any supplement use alongside BPH medications.
Can pygeum replace finasteride or tamsulosin?
No. Pygeum has not been compared head-to-head to pharmaceutical BPH treatments in adequately powered trials. For mild symptoms it may be sufficient; for moderate-to-severe BPH it should complement, not replace, physician-supervised care.
Related ingredients and articles
Saw Palmetto
The most studied herbal BPH supplement — often paired with pygeum.
Best Prostate Supplements (2026)
How pygeum, saw palmetto, beta-sitosterol, and stinging nettle compare.
Schisandra
Another herb with notable drug-interaction cautions — a useful contrast.
Natural BPH Treatments: Evidence Review
A clinician-reviewed comparison of all major botanical options for BPH.
Disclaimer: This information is for educational purposes only and should not replace medical advice. Always consult a qualified healthcare provider before starting any supplement, especially if you have a medical condition, are pregnant, or take prescription medications. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.